A comparative study reveals that dasatinib-quercetin reduces senescence and fibrosis in intervertebral disc degeneration, while navitoclax shows no benefit, highlighting DQ’s potential for affor...
New research links exercise-induced gut microbiome changes to better physical function in seniors, suggesting personalized probiotics could enhance healthy aging. Regular moderate activity boosts bene...
A March 2025 study shows mild acidosis increases frailty risk by 40% in seniors with normal kidney function, pointing to dietary interventions and alkali supplementation. A March 2025 study found low ...
New single-cell studies reveal distinct immune aging trajectories in women and men, with implications for personalized vaccines, autoimmune monitoring, and cancer screening. The immune system ages dif...
A 2023 study in the Journal of Cachexia, Sarcopenia and Muscle finds rapamycin reduces muscle protein synthesis after exercise in older adults, highlighting trade-offs in longevity strategies. Recent ...
Recent studies reveal that aligning meal times with circadian rhythms can slow biological aging and improve metabolic health, offering non-pharmaceutical strategies for longevity. New research highlig...
Recent studies show that FDA-approved antiretroviral FTC/TAF may slow aging by reducing retrotransposon activity, highlighting a promising gerotherapeutic approach with broad accessibility. Groundbrea...
Recent studies show influenza vaccination lowers heart attack and stroke risks by up to 28% in older adults, emphasizing its role in cardiovascular prevention. Influenza vaccination significantly cuts...
A new multi-phase clinical trial on rapamycin aims to establish safe dosing for anti-aging, bridging the gap between off-label use and scientific validation in longevity medicine. Recent advancements ...
Phase 1 trial of RLS-1496 demonstrates safety with no severe adverse events and significant reduction in inflammatory markers, highlighting its potential as a senolytic therapy for skin conditions lik...
